Arkolith/Insider Trading/GYRE/Form 4/A

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4/A · filed Jan 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2025Sell(S)833$11.85$10K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001140361-25-000827) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML